Hirschsprung's Disease
6
1
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Sacral Neuromodulation in Children and Adolescents
MSOT and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bowel Emptying Disorders
Prospective Evaluation of the Efficacy and Safety of Submucosal Endoscopy
Effects of Butyrate Enemas on Postoperative Intestinal Mobility Disorders in Hirschsprung's Disease
Electrophysiological Activity of the Anorectum in Children Suspected of Hirschsprung Disease
Endoscopic Mucosal Resection (EMR) for Diagnosis of Hirschsprung's Disease